FDA Authorizes Pfizer Booster for Kids 5-11, Sends to CDC for Approval

Boosters could become available as early as Friday if approved by the CDC, which could come Thursday

NBCUniversal Media, LLC

The FDA announced Tuesday that it has opened the eligibility requirements for the Pfizer coronavirus booster to include children 5 to 11.

The CDC’s Advisory Committee on Immunization Practices is expected to review and issue its recommendation Thursday, with boosters becoming available as early as Friday if approved.

The amended emergency use authorization means that upon CDC approval, children 5 to 11 will be able to receive a single coronavirus booster shot at least five months after receiving the initial two doses.

The FDA’s announcement comes as health officials are dealing with a wave of new infections by the omicron variant, which appears to be more able to breakthrough immunity granted by vaccines or prior infections.

“The omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” said FDA Commissioner Dr. Robert M. Califf in a statement.

Data from the CDC shows that less than a third of American children between the ages of 5 and 11 have currently received two doses of the coronavirus vaccine.

UCLA's Dr. Timothy Brewer says coronavirus vaccine booster doses can help your immune system against the Omicron variant much better than your first and second shots. Immune systems that have received more doses are able to have "a broader response," he explains.
Contact Us